Tyndall Capital Partners L P
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Tyndall Capital Partners L P reported 1 stock position worth $527 thousand. Its top holding was Cyclerion Therapeutics at 100.0% of the portfolio. Compared with Q4 2023, it added to 1. The biggest buy was Cyclerion Therapeutics (shares +0%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001219314
- Portfolio Value
- $527K (Q1 2024)
- SEC Filing
- 0001493152-24-019867 ↗ filed May 15, 2024
Holdings Value
Holdings 1 stocks · $527K
| CYCLERION THERAPEUTICS INC | 100.00% | 164,777 | $527K | Add +0.2% |
Portfolio Sells Q4 2023 → Q1 2024
| None this quarter. | |||
Portfolio Buys Q4 2023 → Q1 2024
| CYCLERION THERAPEUTICS INC | Add +0.2% | 100.00% | 0.00 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 0 | $0 | |
| Q4 2025 | 0 | $0 | |
| Q3 2025 | 0 | $0 | |
| Q2 2025 | 1 | $452K | CYCLERION THERAPEUTICS INC |
| Q1 2025 | 1 | $412K | CYCLERION THERAPEUTICS INC |
| Q4 2024 | 1 | $531K | CYCLERION THERAPEUTICS INC |
| Q3 2024 | 1 | $427K | CYCLERION THERAPEUTICS INC |
| Q2 2024Amended | 1 | $379K | CYCLERION THERAPEUTICS INC |
| Q1 2024 | 1 | $527K | CYCLERION THERAPEUTICS INC |